255 — Lung Kee group Cashflow Statement
0.000.00%
- HK$878.03m
- HK$339.21m
- HK$1.55bn
- 68
- 81
- 54
- 79
Annual cashflow statement for Lung Kee group, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 221 | 315 | 21.7 | -113 | -19.4 |
Depreciation | |||||
Non-Cash Items | -0.786 | -11 | -33.7 | -6.14 | -3.63 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -11.4 | -107 | -69.8 | 26.9 | 81.7 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 355 | 354 | 76.9 | 77.2 | 226 |
Capital Expenditures | -113 | -201 | -182 | -113 | -35.5 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 18.9 | 24.5 | 24.6 | 14.9 | 11.2 |
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -94.2 | -177 | -158 | -98.1 | -24.4 |
Financing Cash Flow Items | -0.509 | -0.455 | -0.363 | -0.406 | -0.281 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -139 | -278 | -169 | -73.9 | -67.3 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 165 | -85 | -297 | -108 | 118 |